Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fuster

Showing results (201-210 of 512) with videos related to

Pageof 52
Sort By:
Hospital Practice (Office Ed.)|April 15, 1988
Ischemia and infarction III. Pathogenesis of coronary occlusionB Stein, D H Israel, M Cohen, et al.
International Journal of Cardiology|February 1, 1988
Anticoagulation clinics and the monitoring of anticoagulant therapyR Charney, E Leddomado, D N Rose, et al.
The New England Journal of Medicine|January 30, 1992
The pathogenesis of coronary artery disease and the acute coronary syndromes (2)V Fuster, L Badimon, J J Badimon, et al.
Chest|February 1, 1989
Coronary thrombolysisJ A Cairns, R Collins, V Fuster, et al.
Annales Medico-Psychologiques|August 1, 1993
[Psychological effects of heart surgery. Preliminary study]H C Denber, V Fuster, M A Ergin, et al.
Circulation|March 1, 1993
Coronary atherosclerosis. A multifactorial diseaseJ J Badimon, V Fuster, J H Chesebro, et al.
Journal of the American College of Cardiology|February 1, 1993
Exogenous prostacyclin decreases vasoconstriction but not platelet thrombus deposition after arterial injuryJ Y Lam, J H Chesebro, L Badimon, et al.
Circulation|July 13, 2000
Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survivalS K Sharma, A Kini, J D Marmur, et al.
Circulation|June 20, 2001
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart AssociationJ Hirsh, S S Anand, J L Halperin, et al.
Thrombosis and Haemostasis|July 1, 1997
The unstable atherosclerotic plaque: clinical significance and therapeutic interventionV Fuster, J T Fallon, J J Badimon, et al.
Pageof 52

Showing results (201-210 of 512) with videos related to

Sort By:
Pageof 52
Hospital Practice (Office Ed.)|April 15, 1988
Ischemia and infarction III. Pathogenesis of coronary occlusionB Stein, D H Israel, M Cohen, et al.
International Journal of Cardiology|February 1, 1988
Anticoagulation clinics and the monitoring of anticoagulant therapyR Charney, E Leddomado, D N Rose, et al.
The New England Journal of Medicine|January 30, 1992
The pathogenesis of coronary artery disease and the acute coronary syndromes (2)V Fuster, L Badimon, J J Badimon, et al.
Chest|February 1, 1989
Coronary thrombolysisJ A Cairns, R Collins, V Fuster, et al.
Annales Medico-Psychologiques|August 1, 1993
[Psychological effects of heart surgery. Preliminary study]H C Denber, V Fuster, M A Ergin, et al.
Circulation|March 1, 1993
Coronary atherosclerosis. A multifactorial diseaseJ J Badimon, V Fuster, J H Chesebro, et al.
Journal of the American College of Cardiology|February 1, 1993
Exogenous prostacyclin decreases vasoconstriction but not platelet thrombus deposition after arterial injuryJ Y Lam, J H Chesebro, L Badimon, et al.
Circulation|July 13, 2000
Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survivalS K Sharma, A Kini, J D Marmur, et al.
Circulation|June 20, 2001
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart AssociationJ Hirsh, S S Anand, J L Halperin, et al.
Thrombosis and Haemostasis|July 1, 1997
The unstable atherosclerotic plaque: clinical significance and therapeutic interventionV Fuster, J T Fallon, J J Badimon, et al.
Pageof 52